Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by Rumpl3StiltSkin


V.TLT

RE:RE:RE:RE:RE:Dr. Chamie Interview - Quilt 3.032 study (N-803 + BCG)

Right Eoga, I think TLT has a chance to prove that it can get the CRs...

April 20, 2023

V.TLT

RE:RE:RE:Dr. Chamie Interview - Quilt 3.032 study (N-803 + BCG)

Not gonna disagree Eoga, Though I also think that NMIBC dosimetry here is...

April 20, 2023

V.TLT

RE:Dr. Chamie Interview - Quilt 3.032 study (N-803 + BCG)

IF, TLT is also allowed this leeway, to keep treating patients after...

April 20, 2023

V.TLT

RE:RE:RE:RE:RE:RE:RE:I don't see a mystery

The problem, as you state Gman, is BCG, which has to be used with that drug...

April 18, 2023

V.TLT

RE:Could it be?

Anything is possible at this point, with BTD on the docket, basically. But if...

April 18, 2023

V.TLT

RE:RE:RE:I don't see a mystery

Fewer treatments, less toxic, less complicated, probably lower overall cost.....

April 18, 2023

V.TLT

RE:I don't see a mystery

We've gone over this for a long while now. That drug is NOT competition...

April 18, 2023

V.TLT

RE:RE:RE:Up and down and up and down and up and down

it might have been a recent investor wanting to just keep warrants and...

April 18, 2023

V.TLT

RE:RE:the giant sell order

Would be a nice chunk to buy if you wanted a piece of TLT. Anyone know Elon...

April 17, 2023

V.TLT

RE:Someone wants out

or is it someone selling short?

April 17, 2023

V.TLT

RE:RE:RE:Let the 450 day CR% numbers talk.

in TLT's case that 38% CR number should have an asterisk next to it in...

April 17, 2023

V.TLT

RE:RE:Let the 450 day CR% numbers talk.

Geez Slayer, All those treatments and it is a toxic chemo treatment. Not...

April 16, 2023

V.TLT

RE:Sample size : Accelerated versus regular pathway

Poop, As a long time holder of this stock, I've never been more sure of...

April 16, 2023

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Looked at Q3 filing on Sedar again

Yep Lesalpes, We may not know about where we stand with BTD by then, yet I...

April 15, 2023

V.TLT

RE:RE:Posts

Goosey, I don't think, given the numbers that Keytruda doesn't have a...

April 14, 2023

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:Keytruda = $265,000 (17 doses per year)

Oh, right,  I thought you meant BTD... Lol. Yes that report should be...

April 14, 2023

V.TLT

RE:RE:RE:RE:RE:Keytruda = $265,000 (17 doses per year)

So Roswell doesn't have that kind of money? Probably for the best as...

April 14, 2023

V.TLT

RE:RE:RE:RE:RE:RE:Keytruda = $265,000 (17 doses per year)

I think that it might be more that 2 weeks poop. hope I'm wrong. But yeah...

April 14, 2023

V.TLT

RE:RE:RE:Keytruda = $265,000 (17 doses per year)

I wonder if someone like Roswell Park might just pony up a cool $1B since...

April 13, 2023

V.TLT

RE:Looked at Q3 filing on Sedar again

Poop, chill! BTD brings all sorts of goodies. We probably will get a new CEO...

April 13, 2023